Dronedarone produces early regression of myocardial remodelling in structural heart disease.
Left ventricular hypertrophy (LVH) in hypertension is associated with a greater risk of sustained supraventricular/atrial arrhythmias. Dronedarone is an antiarrhythmic agent that was recently approved for the treatment of atrial fibrillation. However, its effect on early regression of LVH has not be...
| Autors principals: | , , , , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Public Library of Science (PLoS)
2017-01-01
|
| Col·lecció: | PLoS ONE |
| Accés en línia: | http://europepmc.org/articles/PMC5697839?pdf=render |